management of adverse events from datopotamab deruxtecan in nsclc
Published 13 hours ago • 6 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:35
challenges in development and clinical use of adcs for lung cancer
-
1:37
tropion-lung01 & tropion-lung05: datopotamab deruxtecan for nsclc
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma
-
5:00
adc-related hematologic adverse events
-
5:15
diagnosing plant disease in the laboratory - the triage approach
-
38:18
an approach to vasculitis
-
1:41
demystifying the mechanisms of cancer drug resistance
-
1:05
metalmark: amivantamab and capmatinib in advanced nsclc
-
51:00
myeloma matters: prevention and management of bispecific antibody–associated adverse events in mu...
-
6:30
managing pulmonary and cardiac adverse events related to adc therapy in breast cancer
-
5:00
hematologic adverse events with adcs in breast cancer: optimal management strategies
-
4:30
risk reduction and management protocols for gastrointestinal adverse events with adc therapy in b...
-
6:21
the management of cardiovascular events
-
57:58
recent advances in lung cancer
-
26:43
special lecture 1apasl oncology 2023 sendai
-
19:56
screening, prevention, and treatment around the world panel ... - 2022 gastric cancer summit
-
32:29
special lecture 3_apasl oncology 2023 sendai
-
34:23
lung cancer survivorship
-
2:42
cancer diagnostics with diamond
-
8:53
interim results from destiny-lung01: t-dxd in her2-overexpressing nsclc